Benzoyl nitrogen mustard derivatives of benzoheterocyclic analogues of netropsin: Synthesis and biological activity

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 11, 2003, Pages 2381-2388

  Baraldi, Pier Giovanni ^a   Romagnoli, Romeo ^a   Bianchi, Nicoletta ^a   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 [1 METHYL 4 [1 METHYL 4 [4 BIS(2 CHLOROETHYL)AMINOBENZAMIDO]IMIDAZOLE 2 CARBOXAMIDO]]DIMETHYLAMINOPROPANE; 3 [1 METHYL 4 [1 METHYL 4 [4 BIS(2 CHLOROETHYL)AMINOBENZAMIDO]PYRAZOLE 2 CARBOXAMIDO]PYRAZOLE 2 CARBOXAMIDO]DIMETHYLAMINOPROPANE; 3 [1 METHYL 5 [1 METHYL 5 [4 N,N BIS(2 CHLOROETHYL)AMINOBENZENE 1 CARBOXAMIDO] (1H) INDOLE 2 CARBOXAMIDO] (1H) INDOLE 2 CARBOXAMIDO]PROPIONAMIDINE; 3 [1 METHYL 5 [5 [4 N,N BIS(2 CHLOROETHYL)AMINOBENZENE 1 CARBOXAMIDO] (1H) INDOLE 2 CARBOXAMIDO] (1H) INDOLE 2 CARBOXAMIDO]PROPIONAMIDINE; 3 [1 METHYL 5 [5 [4 N,N BIS(2 CHLOROETHYL)AMINOBENZENE 1 CARBOXAMIDO]BENZOFURAN 2 CARBOXAMIDO] (1H) INDOLE 2 CARBOXAMIDO]PROPIONAMIDINE; 3 [5 [5 [4 N,N BIS(2 CHLOROETHYL)AMINOBENZENE 1 CARBOXAMIDO] (1H) INDOLE 2 CARBOXAMIDO] (1H) INDOLE 2 CARBOXAMIDO]PROPIONAMIDINE; 3 [5 [5 [4 N,N BIS(2 CHLOROETHYL)AMINOBENZENE 1 CARBOXAMIDO] (1H) INDOLE 2 CARBOXAMIDO]BENZOFURAN 2 CARBOXAMIDO]PROPIONAMIDINE; 3 [5 [5 [4 N,N BIS(2 CHLOROETHYL)AMINOBENZENE 1 CARBOXAMIDO]BENZOFURAN 2 CARBOXAMIDO] (1H) INDOLE 2 CARBOXAMIDO]PROPIONAMIDINE; 3 [5 [5 [4 N,N BIS(2 CHLOROETHYL)AMINOBENZENE 1 CARBOXAMIDO]BENZOFURAN 2 CARBOXAMIDO]]PROPIONAMIDINE; ANTINEOPLASTIC AGENT; BENZOFURAN DERIVATIVE; CONGOCIDINE DERIVATIVE; DNA FRAGMENT; INDOLE DERIVATIVE; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ERYTHROID CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

HUMAN IMMUNODEFICIENCY VIRUS; MURINAE;

EID: 0038639228     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00144-5     Document Type: Article

References (24)

1. (a) Marchini S., Broggini M., Sessa C., D'Incalci M. Exp. Opin. Invest. Drugs. 10:2001;1703.
2. (b) Baraldi P.G., Cacciari B., Spalluto G., Romagnoli R. Exp. Op. Ther. Pat. 6:2000;891
3. (c) Cozzi P., Mongelli N. Curr. Pharm. Des. 4:1998;181.
4. Julia M.M., Préau-Joseph N. Compt. Rend. Acad. Sci. 257:1963;1115.
5. Zunino F., Animati F., Capranico G. Curr. Pharm. Des. 1:1995;83.
6. Krowicki K., Balzarini J., De Clercq E., Newman R.A., Lown J.W. J. Med. Chem. 31:1988;341.
7. Wyatt M.D., Garbiras B.J., Haskell M.K., Lee M., Souhami R.L., Hartley J.A. Anti-Cancer Drug Des.ign. 9:1994;511.
8. Lee H.H., Boyd M., Gravatt G.L., Denny W.A. Anti-Cancer Drug Des. 6:1991;501.
9. Lee M., Rhodes A.L., Wyatt M.D., D'Incalci M., Forrow S., Hartley J.A. J. Med. Chem. 36:1993;863.
10. (a) Boger D.L., Boyce C.W., Garbaccio R.M., Golberg J.A. Chem. Rev. 97:1997;787
11. (b) Zhou Q., Duan W., Simmons D., Shayo Y., Raymond M.A., Dorr R.T., Hurley L.H. J. Am. Chem. Soc. 123:2001;4865
12. Wang Y., Yuan H., Ye W., Wright S.C., Wang H., Larrick J.W. J. Med. Chem. 43:2000;1541.
13. (a) . Compound 13 was synthesized following the procedure reported in the article: Baraldi P.G., Cozzi P., Geroni C., Mongelli N., Romagnoli R., Spalluto G. Bioorg. Med. Chem. 17:1999;251
14. (b) . Compound 14 was synthesized following the procedure reported in the article: Baraldi P.G., Romagnoli R., Spalluto G., Cozzi P., Mongelli N., Bianchi N., Gambari R. Arzneimittel-Forschung/Drug Research. 50:2000;309
15. (c) . Compounds 15, 16 and 17 were synthesized following the procedure reported in the article: Baraldi P.G., Romagnoli R., Beria I., Cozzi P., Geroni G., Mongelli N., Bianchi N., Mischiati C., Gambari R. J. Med. Chem. 43:2000;2675.
16. For the compound 19 see: Lee H.H., Cain B.F., Denny W.A., Buckleton J.S., Clark G.R. J. Org. Chem. 54:1989;428. The derivative 20 was synthesized following the procedure reported in the article: Lown J.W., Krowichi K. J. Org. Chem. 52:1987;3493.
17. For the compound 19 see: Lee H.H., Cain B.F., Denny W.A., Buckleton J.S., Clark G.R. J. Org. Chem. 54:1989;428. The derivative 20 was synthesized following the procedure reported in the article: Lown J.W., Krowichi K. J. Org. Chem. 52:1987;3493.
18. Compound 24 has been already synthesized: Nishiwaki E., Tanaka S., Lee H., Shibuya M. Heterocycles. 27:1988;1945.
19. (a) Feriotto G., Mischiati C., Gambari R. Biochem. J. 299:1994;451
20. (b) Feriotto G., Ciucci A., Mischiati C., Animati F., Lombardi P., Giacomini P., Arcamone F., Gambari R. Eur. J. Pharmacol. 267:1994;143.
21. (c) Feriotto G., Mischiati C., Bianchi N., Passadore M., Gambari R. Eur. J. Pharmacol. 290:1995;85
22. (d) Gambari R., Feriotto G., Rutigliano C., Bianchi N., Mischiati C. J. Pharmacol. Exp. Ther. 294:2000;370.
23. Bianchi N., Ongaro F., Chiarabelli C., Gualandi L., Mischiati C., Bergamini P., Gambari R. For culture of K562 cells and analysis of antiproliferative activity see: Biochem. Pharmacol. 60:2000;31.
24. Bianchi N., Chiarabelli C., Borgatti M., Mischiati C., Fibach E., Gambari R. Br. J. Haematol. 113:2001;951.